The Team Behind Juvelixir
Dr. Robert Heller, MD
60+ years in internal medicine, preventive care, and nutrition. Developed preceptor programs at Cedars-Sinai Medical Center and the University of Pennsylvania Medical School. Principal Investigator in more than 50 clinical research trials, including studies for Merck, Pfizer, Amgen, AbbVie, Astellas, and Moderna. Helped develop the Coronary Calcium Scan.
Beyond medicine, Dr. Heller has led ventures across biotechnology and healthcare business: former CEO of Edge-3D, LLC, a developer of advanced digital 3-D microscope technology; CEO or Chairman for startups spanning nutrition, cardiology, and neuroscience; and medical consultant to organizations including Volkswagen of America, Sony, and Weider Nutritional Group.
He has initiated and negotiated hospital and medical center acquisitions, published scientific articles and book contributions in nutrition and neuroscience, and previously served as a Director of the Prometheus Foundation to Retard Human Aging and a member of the Tech Coast Angels.
Material Connection Disclosure: Dr. Heller is a co-founder of Live Longer, Inc. and has a financial interest in Juvelixir.
Dimitri Villard, MS
Dimitri Villard founded Live Longer specifically to translate the most promising aging research into formulas built for everyday use. He previously co-founded biotech company Pivotal BioSciences with senior faculty at the USC Keck School of Medicine. He played a key role in the formation of the USC Institute for Integrative Health and was an early member of the American Academy of Anti-Aging Medicine and the Southern California Biomedical Council. His broader career includes leadership roles across biotech, finance, motion pictures and technology, including CEO of Peer Media Technologies, Director at investment banking firm Société Générale, and Managing Director at Laidlaw & Co. He is a member of TCA Venture Group, one of the the largest and most active angel investment networks in the United States, and serves as an advisor to numerous early stage companies.
His role is to make sure the science makes it into the bottle, exactly as the research supports.
Dr. Terry Shirvani, ND
Dr. Shirvani has formulated for The Chopra Center, Traditional Medicinals, and Progressive Labs. Former Senior Scientist, Life Extension and Chief Science Officer for GOLO, formulation-focused roles throughout.
National University of Natural Medicine doctoral graduate. Operates by the naturopathic principle: patient well-being first, always. Dr. Shirvani has played a leading role in industry compliance with and implementation of dietary supplement Good Manufacturing Practices.
Dr. Fady Hannah-Shmouni, MD, FRCPC
Former Director, NIH Graduate Medical Education. Principal Investigator of neuroendocrine genetics at the National Institute of Child Health. Board-certified in Internal Medicine, Endocrinology, and Metabolism.
Editor-in-Chief, Endocrine and Metabolic Science (Elsevier). 100+ published articles on stress, hormones, and aging. Dr. Hannah-Shmouni advises on ingredient selection, dosing protocols, and the endocrine and metabolic science underlying the Juvelixir formula.